4//SEC Filing
MEDIMMUNE INC /DE 4
Accession 0001123292-07-000537
CIK 0000873591operating
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 5:19 PM ET
Size
20.5 KB
Accession
0001123292-07-000537
Insider Transaction Report
Form 4
HACKMAN FRANKLIN BARBARA
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2007-06-18−25,000→ 0 totalExercise: $27.12Exp: 2016-06-30→ Common Stock (25,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-06-18−30,000→ 0 totalExercise: $24.04Exp: 2009-06-30→ Common Stock (30,000 underlying)
Footnotes (7)
- [F1]This option, which provided for vesting in four equal annual installments beginning on 06/30/2000, was cancelled pursuant to the merger agreement between the issuer and AstraZeneca PLC in exchange for a cash payment of $33.96, representing the difference between the exercise price of the option and $58.00 per share.
- [F2]This option, which provided for vesting in four equal annual installments beginning on 06/30/2002, was cancelled in the merger in exchange for a cash payment of $10.80 per share, representing the difference between the exercise price of the option and $58.00 per share.
- [F3]This option, which provided for vesting in four equal annual installments beginning on 06/30/2003, was cancelled in the merger in exchange for a cash payment of $31.60 per share, representing the difference between the exercise price of the option and $58.00 per share.
- [F4]This option, which provided for vesting in four equal annual installments beginning on 06/30/2004, was cancelled in the merger in exchange for a cash payment of $22.16 per share, representing the difference between the exercise price of the option and $58.00 per share.
- [F5]This option, which provided for vesting in four equal annual installments beginning on 06/30/2005, was cancelled in the merger in exchange for a cash payment of $34.83 per share, representing the difference between the exercise price of the option and $58.00 per share.
- [F6]This option, which provided for vesting in four equal annual installments beginning on 06/30/2006, was cancelled in the merger in exchange for a cash payment of $30.88 per share, representing the difference between the exercise price of the option and $58.00 per share.
- [F7]This option, which provided for vesting in four equal annual installments beginning on 06/30/2007, was cancelled in the merger in exchange for a cash payment of $30.88 per share, representing the difference between the exercise price of the option and $58.00 per share.
Documents
Issuer
MEDIMMUNE INC /DE
CIK 0000873591
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000873591
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 5:19 PM ET
- Size
- 20.5 KB